Trial RTOG-1008


A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors.

Type: Treatment
Phase: Phase II/III
Status: Closed to Accrual with Ongoing Follow-up
Treatments: Chemotherapy: Systemic, Radiation: External
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Richard Jennelle, M.D.
Other Trial Staff:  Alicia Bogardus, Coordinator, Lusine Raddatz, D.M., Shamim Jhimlee, Coordinator

Staff may log in to see study documents.







For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.